Our work not only has implications for understanding the impact of phospholipids on behavior but also may have clinical relevance, because PITPNC1 is upregulated in many metastatic tumors (Halberg et al., 2016) and polymorphisms in PITPNC1 have been linked to type 2 diabetes mellitus (Greenawalt et al., 2012, Liu et al., 2017). Here, PITPNC1 is linked to diabetes mellitus.